Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Person › Details

Britt Meelby Jensen (Zealand Pharma A/S (Nasdaq: ZEAL))

Meelby Jensen, Britt (Zealand Pharma 201508 CEO)


Organisation Organisation Zealand Pharma A/S (Nasdaq: ZEAL)
  Group Zealand Pharma (Group)
Products Product Lyxumia® (Adlyxin™)
  Product 2 LixiLan®
Document Source Zealand Pharma A/S. (8/28/15). "Press Release: Financial Results in Line with Expectations and Important Progress of the Pipeline". Copenhagen.

Record changed: 2018-02-20


Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Britt Meelby Jensen

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81

» top